This inventor holds 31 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Medical Devices. Top assignees: Advanced Cardiovascular Systems, Inc., Abbott Cardiovascular Systems, Inc., Tyco Electronics Corporation. Active years: 2001-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sunnyvale, CA (US) (2010)
- San Jose, CA (US) (2001 - 2014)
Company Filing History:
22 out of 1,523 
8 out of 1,196 
1 out of 2,043 
Years Active: 2001-2014
Areas of Expertise:
Title: Murthy V Simhambhatla: Innovator in Cardiac Treatment Technologies
Introduction: Murthy V Simhambhatla, based in Sunnyvale, CA, is a prolific inventor with a remarkable portfolio of 31 patents. His contributions to the field of cardiology have led to advancements in methods, devices, and compositions aimed at treating myocardial conditions, showcasing his commitment to innovation in healthcare.
Latest Patents: Among his latest innovations, Simhambhatla has developed patent methodologies and compositions to address myocardial infarction. One embodiment of his work focuses on preventing the remodeling of the infarct zone of the ventricle. Additionally, he incorporates structurally reinforcing agents to bolster heart functionality and compliance. His inventions further explore mechanisms to prevent thinning of the ventricular infarct zone through cross-linking of collagen, enhancing the stability and integrity of the heart tissue. Furthermore, these reinforcing agents may work synergistically with other therapeutic agents, including pro-fibroblastic and angiogenic agents, to optimize treatment outcomes.
Career Highlights: Throughout his career, Simhambhatla has made significant strides while working with notable organizations such as Advanced Cardiovascular Systems, Inc. and Abbott Cardiovascular Systems, Inc. His roles in these companies have positioned him at the forefront of cardiac device innovation, greatly impacting patient care.
Collaborations: In his quest for innovation, Simhambhatla has collaborated with esteemed colleagues including Eugene T Michal and Charles David Claude. Their joint efforts have fostered a collaborative environment conducive to developing cutting-edge cardiac therapies.
Conclusion: Murthy V Simhambhatla has carved a niche for himself as an innovator in the area of cardiac health. With a solid foundation of patents and collaboration, he continues to contribute valuable advancements that hold the potential to improve treatment for myocardial conditions, ultimately enhancing patient outcomes in cardiovascular medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile